©

2019 Mursla Ltd.

Hauser Forum, 3 Charles Babbage Rd CB3 0GT, Cambridge, U.K.

  • Twitter - White Circle
  • LinkedIn - White Circle

Novel early cancer detection platform.

Tracing tumour in the blood.

On-chip platform technology enabling the ultrasensitive quantification and discovery of exosomes (and their biomarker cargo) shed by tumours and the cancer micro-environment in the blood.

NPQuantumSense

Platform technology based on nanogap electrodes generating quantum phenomena in biofluids to deliver a novel detection approach for bioactive disease target.

  • Quantum manipulation & sensing in biofluids

  • On-chip format

  • Moore's law scalability

Illustration of nanogap electrodes on chip

Cancer Exosome Targets

Exosomes are the future of early cancer detection.

  • Snapshot of tumour biomarker cargo

  • Contain rare -omics information

  • Influence the tumour microenvironment

Illlustration of exosomes

Latest News